Monitor the redemption election deadline (Nov 6, 2026) and the shareholder vote outcome on Nov 10, 2026. High redemptions would signal lack of confidence and reduce the SPAC's ability to close a future deal. The stock trades near trust value, limiting downside but also upside absent a credible new target.
Price Chart
Executive Summary
Aimei Health Technology Co., Ltd. (AFJK) is seeking shareholder approval at an extraordinary general meeting on November 10, 2026, to extend its SPAC deadline from December 6, 2026 to December 6, 2027, following the termination of its business combination agreement with United Hydrogen Group Inc. on July 7, 2026 due to a failure to obtain Chinese regulatory approval. The extension is critical to avoid liquidation and allow time to find a new target, but the prior deal's collapse and the need for a 12-month extension signal significant execution risk.
Key Facts
- The Company's prior business combination with United Hydrogen Group Inc. was terminated on July 7, 2026 because required CSRC approval was not obtained.
- Shareholders are asked to approve extending the deadline to complete a business combination from 36 months (Dec 6, 2026) to 48 months (Dec 6, 2027) post-IPO.
- Insiders (Sponsor, directors, officers) beneficially own ~64.96% of outstanding shares and will vote FOR all proposals; they have strong incentive to avoid liquidation as their Founder Shares and Private Units would expire worthless.
- Public shareholders may redeem shares at ~$12.25 per share (Trust Account value as of Oct 2, 2026) if the extension is approved; the stock closed at $12.11 on the record date.
- The Trust Account held $12,740,939.68 as of the record date; redemptions could significantly reduce available funds for a future deal.
- The Sponsor must deposit the lesser of $80,000 or $0.033 per outstanding public share for each monthly extension to keep the SPAC alive.
- Auditor MaloneBailey, LLP is proposed for reappointment for FY2026; audit fees were $160,000 (FY2024) and $130,000 (FY2025).
Financial Impact
Trust Account value ~$12.74M as of Oct 2, 2026; per-share redemption price ~$12.25. Redemption could drain trust, leaving minimal capital for a new deal.
Risk Factors
- Shareholders may not approve the extension, forcing liquidation by Dec 6, 2026.
- Even if approved, high redemptions could leave insufficient trust funds to attract a quality business combination target.
- The Company has no current definitive agreement; finding and closing a new deal within 12 months is uncertain.
- Insiders control ~65% of votes, making approval likely, but the lack of a new target creates overhang.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001493152-26-047583 |
| Document: 0001493152-26-047583-index-headers.html | 0001493152-26-047583 |
| Document: 0001493152-26-047583-index.html | 0001493152-26-047583 |
| Document: 0001493152-26-047583.txt | 0001493152-26-047583 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | DEF 14A | $12.10 $12.05 | ▲ +0.41% | ▲ +0.49% | $12.05 (+0.41%) |
Oct 5, 2026 22d ago | 8-K | $12.35 $12.50 | ▲ +1.21% | ▲ +1.35% | $12.05 (−2.43%) |
Sep 3, 2026 7w ago | 8-K | $12.20 $12.30 | ▲ +0.82% | ▲ +1.97% | $12.05 (−1.23%) |
Jun 29, 2026 17w ago | 8-K | $30.30 $27.27 | ▼ −10.00% | ▼ −10.61% | $12.05 (−60.23%) |
May 20, 2026 22w ago | Press Release | $40.50 $41.52 | ▼ −2.52% | ▼ −0.92% | $12.05 (+70.25%) |
Apr 21, 2026 27w ago | Press Release | $41.38 $46.12 | ▼ −11.44% | ▼ −10.36% | $12.05 (+70.88%) |
Mar 4, 2026 33w ago | 8-K | $30.74 $26.76 | ▼ −12.95% | ▼ −10.71% | $12.05 (−60.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers